Caccinia Crassifolia

Caccinia crassifolia  O. Kuntze.

1. Taxonomic, Nomenclature & Therapeutic Summary Table

Botanical Attribute Pharmacognostic & Therapeutic Specification
Synonym C. glauca Savi.
Family Boraginaceae.
Habitat Native to Baluchistan. Available in Indian market as Gaozabaan.
Unani Gaozabaan. (According to National Formulary of Unani Medicine, Borago officinalis Linn. and other species of Boraginaceae are used as Gaozabaan.)
Action Leaf—diuretic, antiinflammatory, demulcent; used for strangury, asthma and cough.
Taxonomic Cohort Genus Caccinia (1 documented species); Family Boraginaceae (16 documented species).

2. Classical Nomenclature, Taxonomy & Biogeographical Context

Caccinia crassifolia (taxonomically cited with authority O. Kuntze.) is an established medicinal plant species in Indian materia medica. It is classified under the botanical family Boraginaceae (primary family classification: Boraginaceae), placing it within a well-defined chemotaxonomic group of medicinal flora. In classical and modern botanical literature, the species is cross-referenced under the botanical synonymy C. glauca Savi, which is synchronized to prevent taxonomic ambiguity across regional herbal formularies. Biogeographically, its documented habitat and ecological distribution span: Native to Baluchistan. Available in Indian market as Gaozabaan.

Across classical and vernacular Indian systems of medicine, Caccinia crassifolia is recognized under distinct polyglot nomenclature: in the Unani-Tibb materia medica (recorded in The National Formulary of Unani Medicine and CCRUM literature) as Gaozabaan. (According to National Formulary of Unani Medicine, Borago officinalis Linn. and other species of Boraginaceae are used as Gaozabaan.). Romanized Sanskrit and Ayurvedic spellings follow standard National Academy of Ayurveda (Rashtriya Ayurveda Vidyapeeth) transliteration conventions, using double vowels to preserve authentic classical pronunciation across regional medical traditions.

3. Therapeutic Actions, Phytochemistry & Pharmacological Profile

In therapeutic and clinical pharmacognosy, the primary recorded actions and clinical indications of Caccinia crassifolia are: Leaf—diuretic, antiinflammatory, demulcent; used for strangury, asthma and cough. These traditional and clinical attributes reflect the plant part-specific pharmacological profile documented across classical Indian treatises and modern herbal pharmacopoeias.

Experimental phytochemistry, active chemical constituents, and pharmacological screening studies reported for Caccinia crassifolia establish the following evidence base: The stems and leaves gave sapogenins—caccigenin, caccigenin lactone and 23-deoxycaccigenin; rutin and a saponin derived from caccigenin. The leaves also gave a glucoside, caccinin. Caccinin and its aglucone caccinetin (which is the dimethylallyl ester of caffeic acid) is diuretic; saponins exhibit anti-inflammatory activity. Flowers contain pyrrolizidine alkaloid, the diester of retronecine. Benzoic acid has also been isolated from the flowers.

image2

Botanical Reference 1: Caccinia crassifolia — Wikimedia Commons

4. Comparative Genus & Family Pharmacognosy

Within Indian medicinal flora, Caccinia crassifolia stands as a distinct representative of the genus Caccinia. Its therapeutic profile underscores the role of selectively utilized medicinal genera alongside larger polytypic genera.

At the family level, Boraginaceae encompasses 16 documented medicinal species (0.88% of the 1,814-species flora). Other representative medicinal members of Boraginaceae include: Alkanna tinctoria (Alkanet), Anchusa italica (Gojihvikaa), Arnebia benthamii (Kashmiri Gaozabaan), Borago officinalis (Borage), Cordia myxa (Shleshmaataka). In comparative pharmacognosy, evaluating species within the same botanical family aids quality control, authentication of crude drugs, and identification of chemotaxonomic markers.

image1

Figure 1: Quantitative documentation profile across all 16 medicinal species of family Boraginaceae.

5. Pharmacopoeial Standards, Posology & Reference Framework

In clinical and traditional dispensing, preparation and administration of Caccinia crassifolia follow the plant-part modalities specified under its therapeutic action (Leaf—diuretic, antiinflammatory, demulcent; used for strangury, asthma and cough), guided by the standard posological principles of The Ayurvedic Pharmacopoeia of India (Vols. I–IV) and CCRAS formularies. Classical and modern pharmacognostic synchronization for Caccinia crassifolia integrates standards from The Ayurvedic Pharmacopoeia of India, The National Formulary of Unani Medicine, Formulary of Siddha Medicine, The Wealth of India (CSIR), Compendium of Indian Medicinal Plants (CDRI), Dictionary of Indian Medicinal Plants (CIMAP), German Commission E, ESCOP, WHO monographs, British Herbal Pharmacopoeia, and Natural Medicines Comprehensive Database.

Scroll to Top